Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Peter Mahony

Psychiatry Lake Charles, LA Medical Doctor

NPI 1962403303 CMS profile 789185

333 Dr Michael Debakey Dr, Ste. 220, Lake Charles, LA 70601

Open in the dashboard

General payments

$3,741

190 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Peter Mahony of Lake Charles, LA is reported in the CMS Open Payments database as having received $3,741 across 190 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 86th percentile of Psychiatry profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $552 19
2024 General $527 19
2023 General $738 36
2022 General $542 29
2021 General $687 42
2020 General $344 20
2019 General $352 25

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Peter Mahony
  • Psychiatry median
  • Middle half of Psychiatry
  • National median

In program year 2025, general payments to Peter Mahony were reported at $552. Among 14,155 Psychiatry profiles paid that year, the median was $180 and the middle half received between $58 and $685.

Show as a table
Year Peter Mahony Psychiatry median Middle half National median
2019 $352 $184 $59–$605 $163
2020 $344 $119 $36–$372 $114
2021 $687 $143 $43–$576 $132
2022 $542 $153 $50–$590 $149
2023 $738 $170 $56–$651 $160
2024 $527 $179 $57–$673 $164
2025 $552 $180 $58–$685 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Janssen Pharmaceuticals, Inc $626 21 payments
  2. Otsuka America Pharmaceutical, Inc. $610 26 payments
  3. AbbVie, Inc. $555 35 payments
  4. Alkermes, Inc. $448 21 payments
  5. Indivior Inc. $300 18 payments
  6. Allergan Inc. $205 17 payments
  7. Axsome Therapeutics, Inc. $199 6 payments
  8. Lundbeck LLC $191 13 payments
  9. ITI, Inc. $112 7 payments
  10. Sunovion Pharmaceuticals Inc. $102 5 payments
  11. Other $393 21 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $3,714 189 payments
  2. Education $27 1 payment
Products named General payments · program years 2019–2025
  1. SPRAVATO $611 20 payments
  2. ABILIFY MAINTENA $523 25 payments
  3. ARISTADA Cns $396 18 payments
  4. ARISTADA Cns $396 18 payments
  5. VRAYLAR Neuroscience $383 26 payments
  6. LYBALVI $378 17 payments
  7. VRAYLAR Neuroscience $377 26 payments
  8. REXULTI $358 18 payments
  9. PERSERIS $300 18 payments
  10. ARISTADA Cns $247 11 payments
  11. Other $1,776 80 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 36 drugs

Part D claims

1,067

Median for Psychiatry: 574

Drug cost

$67,515

Median for Psychiatry: $27,624

Branded share of claims

19.9%

Median for Psychiatry: 17%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Invega Sustenna Paliperidone Palmitate Brand 13 $43,295
Trintellix Vortioxetine Hydrobromide Brand 13 $9,836
Asenapine Maleate Generic 14 $1,808
Thiothixene Generic 12 $1,467
Dextroamphetamine-Amphetamine Dextroamphetamine/Amphetamine Brand 50 $1,272
Aripiprazole Generic 40 $849
Bupropion Xl Bupropion Hcl Brand 63 $819
Oxcarbazepine Generic 24 $725
Quetiapine Fumarate Generic 74 $722
Clonazepam Generic 74 $668

The 10 drugs with the highest cost, of 36 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 20,488 Part D prescribers listed as Psychiatry; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 8 billing codes

Paid by Medicare

$6,175

Medicare's payments for the services billed

Medicare patients

32

Average age 59

Services billed

103

17 women, 15 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
Depression 72%
High blood pressure 50%
Arthritis 50%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 10 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
SPRAVATO
  • Janssen Pharmaceuticals, Inc $289
$289 — —
PERSERIS
  • Indivior Inc. $67
$67 — —
Azstarys
  • Corium, Inc. $34
$34 — —
COBENFY
  • E.R. Squibb & Sons, L.L.C. $27
$27 — —
VIVITROL
  • Alkermes, Inc. $27
$27 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See all 10 in the dashboard with a free account

Records

190 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Psychiatry in Louisiana

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record